Title: In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole,
vancomycin, fidaxomicin, ridinilazole and ibezapolstat
Version: 3 Date: 18 Feb 2025
Reviewer:  Korakrit Imwattana
Reviewer's report:
Since the resistance prevalence to MTZ and VAN is low and given that the authors used a
different AST method, did the authors confirm the results with an alternative method?
Title: In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole,
vancomycin, fidaxomicin, ridinilazole and ibezapolstat
Version: 3 Date: 18 Feb 2025
Reviewer:  Korakrit Imwattana
Reviewer's report:
Since the resistance prevalence to MTZ and VAN is low and given that the authors used a
different AST method, did the authors confirm the results with an alternative method?
Please review this paper.
user
Title: In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole,
vancomycin, fidaxomicin, ridinilazole and ibezapolstat
Version: 3 Date: 18 Feb 2025
Reviewer:  Korakrit Imwattana
Reviewer's report:
Since the resistance prevalence to MTZ and VAN is low and given that the authors used a
different AST method, did the authors confirm the results with an alternative method?
assistant